表紙
市場調查報告書

院內感染控制的全球市場:成長,趨勢,及預測(2019年∼2024年)

Hospital Acquired Infection Control Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 390866
出版日期 內容資訊 英文 119 Pages
商品交期: 2-3個工作天內
價格
院內感染控制的全球市場:成長,趨勢,及預測(2019年∼2024年) Hospital Acquired Infection Control Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年10月01日內容資訊: 英文 119 Pages
簡介

全球院內感染控制市場在2019年∼2024年間,預測將以7.3%的年複合成長率成長。促進市場成長的主要原因,是由於慢性疾病和手術的住院的增加,各種院內感染的發生率上升,控制感染的設備實施的創新技術等。

本報告提供全球院內感染控制市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品、適應症、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 殺菌劑
    • 消毒劑
    • 其他
  • 各適應症
    • 院內感染肺炎
    • 血流感染
    • 手術部位感染
    • 腸胃感染疾病
    • 泌尿道感染
    • 其他
  • 各終端用戶
    • 醫院、加護病房
    • 門診病人手術、診斷中心
    • 特別護養養老院、孕婦中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • 3M Company
    • Becton, Dickinson and Company
    • Belimed AG
    • Biomerieux Sa
    • Cantel Medical
    • Ethicon
    • Getinge Group
    • Kimberly-Clark Corporation
    • Sterigenics International LLC
    • Steris Corporation

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 53963

Market Overview

The hospital acquired infection control market is expected to witness a CAGR of 7.3% during the forecast period. Certain factors that are driving the market growth include the increase in hospital stay due to chronic diseases and surgeries, a rise in the incidences of different types of hospital-acquired infections, and innovative technologies implemented in devices that control infection.

Hospital-acquired infections are usually caused by pathogens which spread at a very fast rate in the body. Due to the patients' weak immune system and poor conditions in a hospital, the infections spread at a greater speed than the normal infections. These infections are treated by taking antibiotics, by following a proper and healthy diet, and by encouraging the natural healing process. The infection can be prevented by keeping the hospital facility premises clean. The most common type of hospital-acquired infections is a urinary tract infection. The increase in incidences of different types of hospital-acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital-acquired infections are some of the factors that are driving the growth of this market.

Scope of the Report

Hospital acquired infections are also called nosocomial infections and are acquired in hospitals and other healthcare facilities. These infections can occur up to 48 hours after hospital admission or up to three days after discharge or up to 30 days after an operation or in a healthcare facility when the patient was admitted for reasons other than infection.

Key Market Trends

Disinfectant is Expected to Hold Significant Market Share in the Product Type

Disinfection is referred to a process which eliminates many or all pathogenic microorganisms, except the bacterial spores from inanimate objects. This is accomplished by the use of liquid chemicals or wet pasteurization. The efficiency of disinfection is affected by several factors, each of which may limit the efficacy of the process. Some of the factors which have been shown to affect disinfection efficacy are the earlier cleaning of the object, the organic load on the item, the type and level of microbial impurity, the physical configuration of the object (e.g., crevices, hinges, and lumens), the concentration of an exposure time to the germicide, and the pH and temperature of the disinfection process. The US FDA (Food and Drug Administration) maintains a list of high-level disinfectants that can be used to reprocess heat-sensitive medical devices, such as flexible endoscopes.

North America Dominates the Market and Expected to do Same in the Forecast Period

According to the Centers for Disease Control and Prevention (CDC), even though significant progress has been made in stopping some healthcare-associated infection types from spreading, there is still much more work to be done. On any given day, in the United States, around one in 31 hospital patients has at least one healthcare-associated infection. North America, especially the United States and Canada, has made significant progress toward the collective goal of abolishing these HAIs, and as a result, healthcare in this region has become safer now than it was even 10 years ago. Building upon this success and continuing toward the elimination of hospital-acquired infections is critical and this has contributed to the largest market share of North America.

Competitive Landscape

The hospital acquired infection control market is highly competitive and consists of several players. Companies like 3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux Sa, Cantel Medical, Ethicon, Getinge Group, Kimberly-Clark Corporation, Sterigenics International LLC, and Steris Corporation, among others, hold the substantial market share in the hospital acquired infection control market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Hospital Stay Due to Chronic Diseases and Surgeries
    • 4.2.2 Rise in the Incidences of Different Types of Hospital Acquired Infections
    • 4.2.3 Innovative technologies implemented in devices that control infection
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness Regarding Hospital Acquired Infection
    • 4.3.2 Stringent Regulatory Requirements
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product
    • 5.1.1 Sterilants
      • 5.1.1.1 Heat Sterilization Equipment
      • 5.1.1.2 Low Temperature Sterilization Equipment
      • 5.1.1.3 Radiation Sterilization Equipment
      • 5.1.1.4 Other Sterilants
    • 5.1.2 Disinfectants
    • 5.1.3 Other Products
  • 5.2 Indication
    • 5.2.1 Hospital Acquired Pneumonia
    • 5.2.2 Bloodstream Infections
    • 5.2.3 Surgical Site Infections
    • 5.2.4 Gastrointestinal Infections
    • 5.2.5 Urinary Tract Infections
    • 5.2.6 Other Indications
  • 5.3 End User
    • 5.3.1 Hospitals and Intensive Care Units
    • 5.3.2 Ambulatory Surgical and Diagnostic Centers
    • 5.3.3 Nursing Homes and Maternity Centers
    • 5.3.4 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M Company
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Belimed AG
    • 6.1.4 Biomerieux Sa
    • 6.1.5 Cantel Medical
    • 6.1.6 Ethicon
    • 6.1.7 Getinge Group
    • 6.1.8 Kimberly-Clark Corporation
    • 6.1.9 Sterigenics International LLC
    • 6.1.10 Steris Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS